APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphodiesterase (PDE) inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phosphodiesterase (PDE) inhibitors Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchPhosphodiesterase (PDE) inhibitors Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphodiesterase (PDE) inhibitors Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Phosphodiesterase (PDE) inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphodiesterase (PDE) inhibitors Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphodiesterase (PDE) inhibitors Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Phosphodiesterase (PDE) inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phosphodiesterase (PDE) inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phosphodiesterase (PDE) inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phosphodiesterase (PDE) inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phosphodiesterase (PDE) inhibitors include Eli Lilly and Co., Pfizer Inc., GlaxoSmithKline Plc, Bayer AG and Vivus Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phosphodiesterase (PDE) inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phosphodiesterase (PDE) inhibitors market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phosphodiesterase (PDE) inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phosphodiesterase (PDE) inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phosphodiesterase (PDE) inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phosphodiesterase (PDE) inhibitors Market by Company

Eli Lilly and Co.

Pfizer Inc.

GlaxoSmithKline Plc

Bayer AG

Vivus Inc.

Phosphodiesterase (PDE) inhibitors Segment by Type

PDE10 selective inhibitors

PDE1 Selective Inhibitors

PDE2 Selective Inhibitors

PDE3 Selective Inhibitors

PDE4 selective inhibitors

PDE5 selective inhibitors

PDE7 selective inhibitors

Phosphodiesterase (PDE) inhibitors Segment by Application

Oral

Topical

Other

Phosphodiesterase (PDE) inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphodiesterase (PDE) inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphodiesterase (PDE) inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphodiesterase (PDE) inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phosphodiesterase (PDE) inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phosphodiesterase (PDE) inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PDE10 selective inhibitors Table 2. Major Company of PDE1 Selective Inhibitors Table 3. Major Company of PDE2 Selective Inhibitors Table 4. Major Company of PDE3 Selective Inhibitors Table 5. Major Company of PDE4 selective inhibitors Table 6. Major Company of PDE5 selective inhibitors Table 7. Major Company of PDE7 selective inhibitors Table 8. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 10. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type (2021-2026) Table 11. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 12. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type (2021-2026) Table 13. Global Phosphodiesterase (PDE) inhibitors Price by Type (2021-2026) & (US$/L) Table 14. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2027-2032) & (L) Table 15. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type (2027-2032) Table 16. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2027-2032) & (US$ Million) Table 17. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type (2027-2032) Table 18. Global Phosphodiesterase (PDE) inhibitors Price by Type (2027-2032) & (US$/L) Table 19. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 20. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 22. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 24. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 26. Latin America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 28. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (US$ Million) Table 29. Phosphodiesterase (PDE) inhibitors Industry Trends Table 30. Phosphodiesterase (PDE) inhibitors Industry Drivers Table 31. Phosphodiesterase (PDE) inhibitors Industry Opportunities and Challenges Table 32. Phosphodiesterase (PDE) inhibitors Industry Restraints Table 33. Global Phosphodiesterase (PDE) inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2021-2026) Table 35. Global Phosphodiesterase (PDE) inhibitors Sales by Company (2021-2026) & (L) Table 36. Global Phosphodiesterase (PDE) inhibitors Sales Share by Company (2021-2026) Table 37. Global Phosphodiesterase (PDE) inhibitors Market Price by Company (2021-2026) & (US$/L) Table 38. Global Phosphodiesterase (PDE) inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Phosphodiesterase (PDE) inhibitors Major Company Production Sites and Headquarters Table 40. Global Phosphodiesterase (PDE) inhibitors Company, Product Type & Application Table 41. Global Phosphodiesterase (PDE) inhibitors Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Phosphodiesterase (PDE) inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Phosphodiesterase (PDE) inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2021-2026) & (L) Table 46. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2021-2026) Table 47. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2021-2026) & (US$ Million) Table 48. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2021-2026) Table 49. Global Phosphodiesterase (PDE) inhibitors Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 50. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2027-2032) & (L) Table 51. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2027-2032) Table 52. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2027-2032) & (US$ Million) Table 53. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2027-2032) Table 54. Global Phosphodiesterase (PDE) inhibitors Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 55. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 57. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application (2021-2026) Table 58. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 59. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application (2021-2026) Table 60. Global Phosphodiesterase (PDE) inhibitors Price by Application (2021-2026) & (US$/L) Table 61. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2027-2032) & (L) Table 62. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application (2027-2032) Table 63. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2027-2032) & (US$ Million) Table 64. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application (2027-2032) Table 65. Global Phosphodiesterase (PDE) inhibitors Price by Application (2027-2032) & (US$/L) Table 66. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 67. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 69. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 71. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 73. Latin America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 75. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (US$ Million) Table 76. Eli Lilly and Co. Company Information Table 77. Eli Lilly and Co. Business Overview Table 78. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 80. Eli Lilly and Co. Recent Development Table 81. Pfizer Inc. Company Information Table 82. Pfizer Inc. Business Overview Table 83. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 85. Pfizer Inc. Recent Development Table 86. GlaxoSmithKline Plc Company Information Table 87. GlaxoSmithKline Plc Business Overview Table 88. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product Portfolio Table 90. GlaxoSmithKline Plc Recent Development Table 91. Bayer AG Company Information Table 92. Bayer AG Business Overview Table 93. Bayer AG Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 94. Bayer AG Phosphodiesterase (PDE) inhibitors Product Portfolio Table 95. Bayer AG Recent Development Table 96. Vivus Inc. Company Information Table 97. Vivus Inc. Business Overview Table 98. Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 99. Vivus Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 100. Vivus Inc. Recent Development Table 101. North America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 102. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 103. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2026) Table 104. North America Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032) & (L) Table 105. North America Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Country (2027-2032) Table 106. North America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Phosphodiesterase (PDE) inhibitors Market Share by Country (2021-2026) Table 109. North America Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Phosphodiesterase (PDE) inhibitors Market Share Forecast by Country (2027-2032) Table 111. Europe Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 112. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 113. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2026) Table 114. Europe Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032) & (L) Table 115. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Phosphodiesterase (PDE) inhibitors Market Share by Country (2021-2026) Table 119. Europe Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Phosphodiesterase (PDE) inhibitors Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 123. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032) & (L) Table 125. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Share by Country (2021-2026) Table 129. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Share Forecast by Country (2027-2032) Table 131. Latin America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 132. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 133. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2026) Table 134. Latin America Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032) & (L) Table 135. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Phosphodiesterase (PDE) inhibitors Market Share by Country (2021-2026) Table 139. Latin America Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Phosphodiesterase (PDE) inhibitors Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 143. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032) & (L) Table 145. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Share by Country (2021-2026) Table 149. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Phosphodiesterase (PDE) inhibitors Distributors List Table 154. Phosphodiesterase (PDE) inhibitors Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Phosphodiesterase (PDE) inhibitors Image Figure 2. Global Phosphodiesterase (PDE) inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phosphodiesterase (PDE) inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Phosphodiesterase (PDE) inhibitors Sales (2021-2032) & (L) Figure 5. PDE10 selective inhibitors Image Figure 6. Global PDE10 selective inhibitors Sales YoY Growth (2021-2032) & (L) Figure 7. PDE1 Selective Inhibitors Image Figure 8. Global PDE1 Selective Inhibitors Sales YoY Growth (2021-2032) & (L) Figure 9. PDE2 Selective Inhibitors Image Figure 10. Global PDE2 Selective Inhibitors Sales YoY Growth (2021-2032) & (L) Figure 11. PDE3 Selective Inhibitors Image Figure 12. Global PDE3 Selective Inhibitors Sales YoY Growth (2021-2032) & (L) Figure 13. PDE4 selective inhibitors Image Figure 14. Global PDE4 selective inhibitors Sales YoY Growth (2021-2032) & (L) Figure 15. PDE5 selective inhibitors Image Figure 16. Global PDE5 selective inhibitors Sales YoY Growth (2021-2032) & (L) Figure 17. PDE7 selective inhibitors Image Figure 18. Global PDE7 selective inhibitors Sales YoY Growth (2021-2032) & (L) Figure 19. Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Phosphodiesterase (PDE) inhibitors Market Share by Type 2025 VS 2032 Figure 21. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2025 Figure 24. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2025 Figure 27. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Phosphodiesterase (PDE) inhibitors Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Oral Image Figure 34. Global Oral Sales YoY Growth (2021-2032) & (L) Figure 35. Topical Image Figure 36. Global Topical Sales YoY Growth (2021-2032) & (L) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (L) Figure 39. Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Phosphodiesterase (PDE) inhibitors Market Share by Application 2025 VS 2032 Figure 41. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2025 Figure 47. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2025 Figure 51. North America Phosphodiesterase (PDE) inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. North America Phosphodiesterase (PDE) inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Phosphodiesterase (PDE) inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Phosphodiesterase (PDE) inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Europe Phosphodiesterase (PDE) inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Phosphodiesterase (PDE) inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 60. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 64. Latin America Phosphodiesterase (PDE) inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Phosphodiesterase (PDE) inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 68. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Phosphodiesterase (PDE) inhibitors Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Phosphodiesterase (PDE) inhibitors Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • PDE10 selective inhibitors
  • PDE1 Selective Inhibitors
  • PDE2 Selective Inhibitors
  • PDE3 Selective Inhibitors
  • PDE4 selective inhibitors
  • PDE5 selective inhibitors
  • PDE7 selective inhibitors
Applications
  • Oral
  • Topical
  • Other
Companies covered
  • Eli Lilly and Co.
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Bayer AG
  • Vivus Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phosphodiesterase (PDE) inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phosphodiesterase (PDE) inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phosphodiesterase (PDE) inhibitors Market by Type
  6. 1.3.1 PDE10 selective inhibitors
  7. 1.3.2 PDE1 Selective Inhibitors
  8. 1.3.3 PDE2 Selective Inhibitors
  9. 1.3.4 PDE3 Selective Inhibitors
  10. 1.3.5 PDE4 selective inhibitors
  11. 1.3.6 PDE5 selective inhibitors
  12. 1.3.7 PDE7 selective inhibitors
  13. 1.4 Global Phosphodiesterase (PDE) inhibitors Market Size by Type
  14. 1.4.1 Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phosphodiesterase (PDE) inhibitors Industry Trends
  2. 2.2 Phosphodiesterase (PDE) inhibitors Industry Drivers
  3. 2.3 Phosphodiesterase (PDE) inhibitors Industry Opportunities and Challenges
  4. 2.4 Phosphodiesterase (PDE) inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phosphodiesterase (PDE) inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Phosphodiesterase (PDE) inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Phosphodiesterase (PDE) inhibitors Price (2021-2026)
  4. 3.4 Global Phosphodiesterase (PDE) inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phosphodiesterase (PDE) inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Phosphodiesterase (PDE) inhibitors Company, Product Type & Application
  7. 3.7 Global Phosphodiesterase (PDE) inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phosphodiesterase (PDE) inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phosphodiesterase (PDE) inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phosphodiesterase (PDE) inhibitors Tier 1, Tier 2, and Tier 3
4 Phosphodiesterase (PDE) inhibitors Regional Status and Outlook
  1. 4.1 Global Phosphodiesterase (PDE) inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size by Region
  3. 4.2.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phosphodiesterase (PDE) inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phosphodiesterase (PDE) inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phosphodiesterase (PDE) inhibitors by Application
  1. 5.1 Phosphodiesterase (PDE) inhibitors Market by Application
  2. 5.1.1 Oral
  3. 5.1.2 Topical
  4. 5.1.3 Other
  5. 5.2 Global Phosphodiesterase (PDE) inhibitors Market Size by Application
  6. 5.2.1 Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Co.
  2. 6.1.1 Eli Lilly and Co. Company Information
  3. 6.1.2 Eli Lilly and Co. Business Overview
  4. 6.1.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product Portfolio
  6. 6.1.5 Eli Lilly and Co. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 GlaxoSmithKline Plc
  14. 6.3.1 GlaxoSmithKline Plc Company Information
  15. 6.3.2 GlaxoSmithKline Plc Business Overview
  16. 6.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product Portfolio
  18. 6.3.5 GlaxoSmithKline Plc Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Phosphodiesterase (PDE) inhibitors Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Vivus Inc.
  26. 6.5.1 Vivus Inc. Company Information
  27. 6.5.2 Vivus Inc. Business Overview
  28. 6.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio
  30. 6.5.5 Vivus Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Phosphodiesterase (PDE) inhibitors Sales by Country
  2. 7.1.1 North America Phosphodiesterase (PDE) inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phosphodiesterase (PDE) inhibitors Market Size by Country
  6. 7.2.1 North America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Country
  2. 8.1.1 Europe Phosphodiesterase (PDE) inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phosphodiesterase (PDE) inhibitors Market Size by Country
  6. 8.2.1 Europe Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phosphodiesterase (PDE) inhibitors Sales by Country
  2. 10.1.1 South America Phosphodiesterase (PDE) inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phosphodiesterase (PDE) inhibitors Market Size by Country
  6. 10.2.1 South America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phosphodiesterase (PDE) inhibitors Value Chain Analysis
  2. 12.1.1 Phosphodiesterase (PDE) inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phosphodiesterase (PDE) inhibitors Production Mode & Process
  7. 12.2 Phosphodiesterase (PDE) inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phosphodiesterase (PDE) inhibitors Distributors
  10. 12.2.3 Phosphodiesterase (PDE) inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst